Tuesday, November 3, 2026

How New Law Will Transform Human-Derived Fat into High-Value Bio-Materials

Human-derived fat, once medical waste, is now a valuable resource for biotech after new legislation allows its recycling for regenerative medicine.

Behind the Moves: J-Black Reveals the Choreography Secrets of A2O Light’s “NEON”

Choreographer J-Black reveals the behind-the-scenes story of creating the dance for A2O Light's song "NEON".

50-Year-Old Man Sentenced for Repeated Attempts to Import Illegal Firearms

© News1 DB A man in his 50s who tried to import unauthorized air guns and parts has been sentenced to prison...

Health

How Samsung Medical Center Reduced Waste by 80%: A Game-Changer in ESG Management

Hospitals face pressure to adopt eco-friendly practices due to rising concerns over waste and disposable items impacting the environment.

Q901: The Promising New Hope for Pediatric Brain Tumors – What You Need to Know About This FDA-Approved Therapy

Qurient, the major shareholder of DongKoo Bio&Pharma, received FDA approval for a pediatric brain tumor trial of Q901.

IKS014 vs. Enhertu: Can This New HER2 ADC Drug Revolutionize Breast Cancer Treatment?

IKS014 shows a 50% objective response rate in HER2-positive breast cancer patients previously treated with Enhertu.

IMB-105: The Next Breakthrough in Autoimmune Disease Treatment?

IMBiologics partners with GC Pharma to develop next-generation autoimmune disease treatments.

How MEDTIS is Revolutionizing Remote Healthcare in Asia: Insights from Health On Cloud’s CEO

Trust is essential for Korean medical technology to enter foreign markets, according to Jeon Sang-hoon, CEO of Health On Cloud.
Latest

How AMD’s Lisa Su Boosts Korea’s AI Strategy: Key Collaboration Insights

South Korea's AI leaders met with AMD's CEO to enhance cooperation and boost the nation's AI capabilities and infrastructure.

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

Why Celltrion’s STEQEYMA Auto-Injector is a Game Changer for Autoimmune Patients in North America

Celltrion expands its Steqeyma auto-injector lineup in Canada, enhancing market competitiveness and patient accessibility in North America.

Revolutionary CAR-T Treatment SynKIR-310 Outperforms CD19 CAR-T: What This Means for Blood Cancer Patients

Verismo Therapeutics' SynKIR-310 shows superior anti-tumor effects in preclinical studies, promising a safer CAR-T therapy for blood cancers.

New Breakthrough: HER2 Positive Stomach Cancer Treatment with Dual Targeted Therapy Shows 81% Tumor Size Reduction

A study reveals that combining trastuzumab deruxtecan and pertuzumab significantly reduces tumor size in HER2-positive gastric cancer.

LG Uplus Unveils Cutting-Edge IoT Solutions at WATER KOREA 2026: Revolutionizing Water Management

LG Uplus will showcase its IoT solutions for water management at the International Water Industry Expo, enhancing efficiency and safety.

AMD’s Latest MI355 GPU: How Upstage is Revolutionizing AI in South Korea

Upstage secures AMD GPUs for AI development, aiming for 10,000 units to enhance its language model and document processing solutions.

Revolutionizing Business: How SK AX’s AXgenticWire is Transforming Operations with Agentic AI

SK AX launches AXgenticWire, integrating agentic AI to enhance business operations and decision-making through collaborative AI systems.

How MedTech Spotlight 2026 is Connecting Korean Firms with Global Healthcare Leaders

Seoul will host MedTech Spotlight: New Impact Korea 2026 to foster global collaboration in the medical device industry on March 19-20.

How AMD’s New Alliance with Samsung is Set to Transform the AI Semiconductor Landscape in 2026

AMD and Samsung strengthen AI partnership, focusing on next-gen processors and memory for mobile and PC sectors.

HLB Pep Signs Deal with Japan’s ReproCELL to Supply Customized Neoantigen Peptides — The Future of Precision Medicine?

HLB PEP partners with Reprocell to supply customized neo-antigen peptides for personalized cancer treatment, targeting global markets.

Unlocking Treatment Potential: GI-102 and Pasritamig Clinical Trial Insights

GI Innovation has filed an IND application for a clinical trial on a combination therapy for metastatic prostate cancer in South Korea and the U.S.

How Hurom’s Innovative Commercial Juicers Are Revolutionizing the Cold Pressed Juice Market in 2026

Hurom showcased its commercial juicers at major events in New York and Hamburg, targeting the growing cold-pressed juice market.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.